Table 1.
The baseline of the subjects
| Patients | Value | Normal range |
|---|---|---|
| Number | 98 | |
| Age (years old) | 60.28±13.61 | - |
| Duration (months) | (12.00, 123.00) | - |
| BMI (Kg/m2) | 25.05±4.34 | 18.50~24.90 |
| HbA1c (%) | 9.19±2.53 | 4.50-6.30 |
| FPG (mmol/l) | 8.20±2.98 | 3.90-6.10 |
| FINS (mU/L) | (8.24, 22.88) | 2.60-24.90 |
| Testosterone (nmol/L) | 13.51±6.89 | 9.90-27.80 |
| FSH (IU/L) | 8.52±4.88 | 1.50-12.40 |
| LH (ng/ml) | 6.99±3.75 | 1.70-8.60 |
| TOC (ng/ml) | 11.31±3.85 | 14.00-46.00 |
| CTX (ng/ml) | (0.21, 0.55) | <0.85 |
Duration: duration of type 2 diabetes mellitus; BMI: body mass index; FPG: fasting plasma glucose; FINS: fasting insulin level; FSH: follicle-stimulating hormone; LH: luteinizing hormone; TOC: total osteocalcin; CTX: C-terminal telopeptide of type I collagen. Duration, FINS and CTX were not followed the normal distribution, they were expressed as quantile, others were showed as mean ± SD.